Dava Home

FREE SHIPPING ON ORDERS ABOVE ₹599 | GENUINE MEDICINES. DOORSTEP DELIVERED.

Sale!
, , ,

Daxyclot 2.5 – Rivaroxaban Tablets 2.5 mg – 1 x 14 Tablets

Original price was: ₹117.19.Current price is: ₹30.47.

Daxyclot-2.5 is a low-dose oral blood thinner containing 2.5 mg of Rivaroxaban, marketed under DH Healthcare. Belonging to the direct oral anticoagulant (DOAC) class, this specific 2.5 mg strength is widely prescribed in combination with low-dose Aspirin to reduce the long-term risk of stroke, heart attack, and cardiovascular death in adults with stable Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD).

Add to Wishlist
Add to Wishlist

Daxyclot-2.5 (Rivaroxaban Tablets 2.5 mg) provides a highly targeted dual-pathway approach when paired with antiplatelets for long-term atherothrombotic protection. While higher doses (10mg/15mg/20mg) are used for treating active venous clots, this low-dose formulation focuses on prevention in high-risk arterial disease networks.

It is clinically indicated for:

  • Coronary Artery Disease (CAD): Long-term management in patients with chronic stable heart blockages to prevent a secondary myocardial infarction.

  • Peripheral Artery Disease (PAD): Protects limbs and critical blood flow in patients with narrowed leg arteries, reducing the risk of critical limb ischemia or amputation.

  • Dual Pathway Inhibition (DPI): Used alongside low-dose Aspirin to offer superior cardiac protection compared to Aspirin alone.

How it works: Rivaroxaban is a highly selective direct Factor Xa inhibitor. Factor Xa is a pivotal enzyme required for the activation of the body’s coagulation cascade. By binding to Factor Xa at a low therapeutic dose, Daxyclot-2.5 subtly checks thrombin generation, preventing platelets and fibrin from clotting over vulnerable arterial plaques without unnecessarily compromising baseline clotting safety.

Key Benefits

  • Advanced Dual Pathway Protection: Proven to significantly lower cardiac event rates when co-administered with Aspirin.

  • Limb Protection: Crucial for keeping peripheral arteries open and flowing smoothly in PAD profiles.

  • No Routine Lab Monitoring: Eliminates the need for frequent blood tests (like PT/INR updates) required by older options like Warfarin.

  • Quality Controlled: Manufactured under precise therapeutic bio-equivalent guidelines under the DH brand.

Directions for Use

  • Take strictly as prescribed by your Cardiologist, Vascular Surgeon, or Physician.

  • Standard Dosing: Typically taken twice daily (morning and evening) at fixed times, or as directed by your specialist.

  • Food Protocol: The 2.5 mg strength can generally be taken with or without food, but maintaining a uniform routine is advised.

  • How to Swallow: Swallow the tablet whole with a glass of water. Do not crush or chew.

Safety & Precautions

  • Rx Only: A valid medical prescription from a registered practitioner is mandatory before checkout.

  • Bleeding Risk: As a potent blood thinner, it increases the risk of bleeding. Inform your doctor immediately if you experience unusual bruising, prolonged nosebleeds, dark tarry stools, or bleeding gums.

  • Surgeries & Dental Work: Inform all treating dentists or surgeons that you are on Daxyclot-2.5 before any upcoming surgical or invasive procedures.

  • Never Stop Abruptly: Do not skip doses or discontinue the medicine suddenly without consulting your doctor, as this drastically spikes the risk of developing a dangerous blood clot or cardiovascular event.

Storage

  • Store in a cool, dry place below 30°C.

  • Protect from direct sunlight, ambient heat, and moisture.

  • Keep securely out of reach of children.

Weight 0.0002 g
Dimensions 11.5 × 4.5 × 5.5 cm
Composition

Rivaroxaban (2.5 mg)

Type

Direct Oral Anticoagulant (DOAC) / Factor Xa Inhibitor (Low-Dose Regimen)

Primary Use

Prevention of major cardiovascular events (heart attack, stroke) in patients with Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD), usually co-administered with Aspirin.

Action

Selectively blocks Factor Xa to reduce thrombin generation and lower the risk of arterial blood clot formation

Scroll to Top